-+ 0.00%
-+ 0.00%
-+ 0.00%

EXCLUSIVE: PRF Technologies Announces FDA Clearance Of IND Application For OcuRing-K Phase II Clinical Trial

Benzinga·04/28/2026 11:45:09
Listen to the news

Milestone supports advancement of PRF's drop-less ocular drug-delivery platform into next-stage U.S. clinical development for post-cataract pain and inflammation